Loading...

Zota Health Care

NSEI:ZOTA
Snowflake Description

Flawless balance sheet with acceptable track record.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
ZOTA
NSEI
₹5B
Market Cap
  1. Home
  2. IN
  3. Pharmaceuticals & Biotech
Company description

Zota Health Care Limited manufactures and markets pharmaceutical products in India and internationally. The last earnings update was 219 days ago. More info.


Add to Portfolio Compare Print
ZOTA Share Price and Events
7 Day Returns
1.6%
NSEI:ZOTA
-0.2%
IN Pharmaceuticals
-0.4%
IN Market
1 Year Returns
25.4%
NSEI:ZOTA
3.9%
IN Pharmaceuticals
3.3%
IN Market
ZOTA Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Zota Health Care (ZOTA) 1.6% -0.8% 2% 25.4% - -
IN Pharmaceuticals -0.2% 6.8% 2.6% 3.9% -11.9% 42.6%
IN Market -0.4% 7.4% 2.9% 3.3% 42.8% 75.3%
1 Year Return vs Industry and Market
  • ZOTA outperformed the Pharmaceuticals industry which returned 3.9% over the past year.
  • ZOTA outperformed the Market in India which returned 3.3% over the past year.
Price Volatility
Industry
5yr Volatility vs Market

Value

 Is Zota Health Care undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Zota Health Care. This is due to cash flow or dividend data being unavailable. The share price is ₹260.05.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Zota Health Care's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Zota Health Care's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NSEI:ZOTA PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-03-31) in INR ₹4.23
NSEI:ZOTA Share Price ** NSEI (2019-03-22) in INR ₹260.05
India Pharmaceuticals Industry PE Ratio Median Figure of 112 Publicly-Listed Pharmaceuticals Companies 19.79x
India Market PE Ratio Median Figure of 2,729 Publicly-Listed Companies 16.32x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Zota Health Care.

NSEI:ZOTA PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NSEI:ZOTA Share Price ÷ EPS (both in INR)

= 260.05 ÷ 4.23

61.53x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Zota Health Care is overvalued based on earnings compared to the IN Pharmaceuticals industry average.
  • Zota Health Care is overvalued based on earnings compared to the India market.
Price based on expected Growth
Does Zota Health Care's expected growth come at a high price?
Raw Data
NSEI:ZOTA PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 61.53x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
4%per year
India Pharmaceuticals Industry PEG Ratio Median Figure of 32 Publicly-Listed Pharmaceuticals Companies 1.36x
India Market PEG Ratio Median Figure of 595 Publicly-Listed Companies 1.29x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Zota Health Care, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Zota Health Care's assets?
Raw Data
NSEI:ZOTA PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-03-31) in INR ₹39.77
NSEI:ZOTA Share Price * NSEI (2019-03-22) in INR ₹260.05
India Pharmaceuticals Industry PB Ratio Median Figure of 134 Publicly-Listed Pharmaceuticals Companies 1.93x
India Market PB Ratio Median Figure of 3,620 Publicly-Listed Companies 1.11x
NSEI:ZOTA PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NSEI:ZOTA Share Price ÷ Book Value per Share (both in INR)

= 260.05 ÷ 39.77

6.54x

* Primary Listing of Zota Health Care.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Zota Health Care is overvalued based on assets compared to the IN Pharmaceuticals industry average.
X
Value checks
We assess Zota Health Care's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. Zota Health Care has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Zota Health Care expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover Zota Health Care, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
4%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Zota Health Care expected to grow at an attractive rate?
  • Zota Health Care's earnings growth is positive but not above the low risk savings rate of 7.6%.
Growth vs Market Checks
  • Zota Health Care's earnings growth is positive but not above the India market average.
  • Unable to compare Zota Health Care's revenue growth to the India market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
NSEI:ZOTA Future Growth Rates Data Sources
Data Point Source Value (per year)
NSEI:ZOTA Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 4%
India Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 20%
India Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 13.6%
India Market Earnings Growth Rate Market Cap Weighted Average 18.6%
India Market Revenue Growth Rate Market Cap Weighted Average 11.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NSEI:ZOTA Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (11 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in INR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NSEI:ZOTA Past Financials Data
Date (Data in INR Millions) Revenue Cash Flow Net Income *
2018-03-31 779 -44 73
2017-03-31 716 34 55
2016-03-31 647 46 51

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Zota Health Care's earnings are expected to grow by 4% yearly, however this is not considered high growth (20% yearly).
  • Unable to determine if Zota Health Care is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NSEI:ZOTA Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (11 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Zota Health Care Company Filings, last reported 11 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NSEI:ZOTA Past Financials Data
Date (Data in INR Millions) EPS *
2018-03-31 4.23
2017-03-31 3.86
2016-03-31 3.56

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Zota Health Care will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Zota Health Care's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the India market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the India market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Zota Health Care has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Zota Health Care performed over the past 5 years?

  • Zota Health Care's last earnings update was 219 days ago.
The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Zota Health Care's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Zota Health Care's year on year earnings growth rate has been positive over the past 5 years.
  • Zota Health Care's 1-year earnings growth exceeds its 5-year average (31.2% vs 19.5%)
  • Zota Health Care's earnings growth has exceeded the IN Pharmaceuticals industry average in the past year (31.2% vs 16.4%).
Earnings and Revenue History
Zota Health Care's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Zota Health Care Company Filings, last reported 11 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NSEI:ZOTA Past Revenue, Cash Flow and Net Income Data
Date (Data in INR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-03-31 778.52 72.68 81.11
2017-03-31 715.88 55.41 85.30
2016-03-31 647.33 51.09 68.99
2015-03-31 564.63 42.60 53.79
2014-03-31 501.12 31.30 42.32
2013-03-31 439.08 25.55 36.60
2012-03-31 381.43 19.83 32.22

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Zota Health Care has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Zota Health Care used its assets less efficiently than the IN Pharmaceuticals industry average last year based on Return on Assets.
  • Zota Health Care's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Zota Health Care's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Zota Health Care has a total score of 3/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Zota Health Care's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Zota Health Care's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Zota Health Care is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Zota Health Care's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Zota Health Care's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Zota Health Care has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Zota Health Care Company Filings, last reported 11 months ago.

NSEI:ZOTA Past Debt and Equity Data
Date (Data in INR Millions) Total Equity Total Debt Cash & Short Term Investments
2018-03-31 697.78 0.00 24.62
2017-03-31 269.83 40.96 1.37
2016-03-31 214.42 22.26 7.56
2015-03-31 181.02 52.46 1.64
2014-03-31 156.09 48.23 1.43
2013-03-31 138.70 54.10 1.27
2012-03-31 127.07 59.74 1.22
  • Zota Health Care has no debt.
  • Zota Health Care has no debt compared to 5 years ago when it was 39%.
  • Zota Health Care has no debt, it does not need to be covered by operating cash flow.
  • Zota Health Care has no debt, therefore coverage of interest payments is not a concern.
X
Financial health checks
We assess Zota Health Care's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Zota Health Care has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Zota Health Care's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
1.15%
Current annual income from Zota Health Care dividends.
If you bought ₹2,000 of Zota Health Care shares you are expected to receive ₹23 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Zota Health Care's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.5%).
  • Zota Health Care's dividend is below the markets top 25% of dividend payers in India (1.91%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NSEI:ZOTA Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
India Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 69 Stocks 0.7%
India Market Average Dividend Yield Market Cap Weighted Average of 1399 Stocks 1.4%
India Minimum Threshold Dividend Yield 10th Percentile 0.3%
India Bottom 25% Dividend Yield 25th Percentile 0.5%
India Top 25% Dividend Yield 75th Percentile 1.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NSEI:ZOTA Past Annualized Dividends Data
Date (Data in ₹) Dividend per share (annual) Avg. Yield (%)
2018-08-16 3.000 1.142
2018-05-30 3.000 1.256
2017-10-11 2.000 0.971

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • It is too early to tell whether Zota Health Care has stable dividend payments.
  • Zota Health Care only just started paying a dividend, it is too early to tell if payments are increasing.
Current Payout to shareholders
What portion of Zota Health Care's earnings are paid to the shareholders as a dividend.
  • Dividends paid are covered by earnings (1.4x coverage).
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Zota Health Care's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Zota Health Care afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Zota Health Care has a total score of 2/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Zota Health Care's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Moxesh Zota
COMPENSATION ₹0
AGE 27
TENURE AS CEO 2.4 years
CEO Bio

Mr. Moxesh Ketanbhai Zota has been Managing Director and Director at Zota Health Care Limited since October 7, 2016. Mr. Zota is young entrepreneur with experience of 2 years in the industry and forays export business of Zota Health Care. He has completed Bachelor of Pharmacy from Gujarat Technological University and also awarded with degree of Master of Science from BPP University, United Kingdom.

CEO Compensation
  • Insufficient data for Moxesh to compare compensation growth.
  • Moxesh's remuneration is lower than average for companies of similar size in India.
Management Team Tenure

Average tenure and age of the Zota Health Care management team in years:

2.5
Average Tenure
41
Average Age
  • The tenure for the Zota Health Care management team is about average.
Management Team

Moxesh Zota

TITLE
Executive MD & Director
AGE
27
TENURE
2.4 yrs

Viral Mandviwala

TITLE
Chief Financial Officer
COMPENSATION
₹526K
AGE
42
TENURE
4.5 yrs

Ashvin Variya

TITLE
Compliance Officer & Company Secretary
COMPENSATION
₹528K
AGE
27
TENURE
2.5 yrs

Kamlesh Zota

TITLE
Whole-Time Director
AGE
44

Himanshu Zota

TITLE
Whole-Time Director
AGE
43

Manukant Zota

TITLE
Whole-Time Director
AGE
66

Viren Zota

TITLE
Head of Domestic Market
AGE
34

Jatin Zota

TITLE
Head of Domestic Market
AGE
36

Niral Zota

TITLE
Head of Domestic Market
AGE
41
Board of Directors Tenure

Average tenure and age of the Zota Health Care board of directors in years:

3.5
Average Tenure
46.5
Average Age
  • The tenure for the Zota Health Care board of directors is about average.
Board of Directors

Ketankumar Zota

TITLE
Chairman
AGE
51
TENURE
2.5 yrs

Moxesh Zota

TITLE
Executive MD & Director
AGE
27
TENURE
2.4 yrs

Kamlesh Zota

TITLE
Whole-Time Director
AGE
44
TENURE
7.7 yrs

Himanshu Zota

TITLE
Whole-Time Director
AGE
43

Manukant Zota

TITLE
Whole-Time Director
AGE
66

Saileshkumar Shah

TITLE
Non-Executive Independent Director
AGE
60
TENURE
4.5 yrs

Mahesh Prajapati

TITLE
Non-Executive Independent Director
AGE
31
TENURE
4.5 yrs

Varsaben Mehta

TITLE
Non-Executive Independent Director
AGE
49
TENURE
2.5 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Zota Health Care insiders in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (₹) Value (₹)
11. Jan 19 Buy Manukant Zota Individual 10. Jan 19 10. Jan 19 56,000 ₹251.00 ₹14,055,997
11. Jan 19 Buy Ketankumar Zota Individual 09. Jan 19 10. Jan 19 12,000 ₹251.50 ₹3,018,000
08. Dec 18 Buy Ketankumar Zota Individual 03. Dec 18 04. Dec 18 67,000 ₹253.39 ₹16,976,948
05. Dec 18 Buy Himanshu Zota Individual 03. Dec 18 03. Dec 18 16,000 ₹254.65 ₹4,074,400
05. Dec 18 Buy Kamlesh Zota Individual 03. Dec 18 03. Dec 18 13,000 ₹254.65 ₹3,310,450
04. Dec 18 Buy Kamlesh Zota Individual 28. Nov 18 30. Nov 18 41,500 ₹253.85 ₹10,534,699
01. Dec 18 Buy Ketankumar Zota Individual 28. Nov 18 28. Nov 18 10,000 ₹254.00 ₹2,540,000
01. Dec 18 Buy Manukant Zota Individual 28. Nov 18 28. Nov 18 10,000 ₹254.00 ₹2,540,000
29. Nov 18 Buy Himanshu Zota Individual 28. Nov 18 29. Nov 18 50,500 ₹253.65 ₹12,809,179
06. Oct 18 Buy Sunilbhai Doshi Individual 21. Sep 18 28. Sep 18 4,000 ₹274.09 ₹1,096,375
05. Sep 18 Buy Himanshu Zota Individual 03. Sep 18 03. Sep 18 17,000 ₹285.10 ₹4,846,699
01. Sep 18 Buy Himanshu Zota Individual 29. Aug 18 29. Aug 18 8,000 ₹286.00 ₹2,288,000
31. Aug 18 Buy Ketankumar Zota Individual 28. Aug 18 30. Aug 18 24,000 ₹289.71 ₹6,874,598
29. Aug 18 Buy Manukant Zota Individual 27. Aug 18 28. Aug 18 18,000 ₹286.79 ₹5,162,270
07. Jun 18 Buy Kamlesh Zota Individual 05. Jun 18 05. Jun 18 9,000 ₹212.50 ₹1,912,500
07. Jun 18 Sell Ketankumar Zota Individual 05. Jun 18 05. Jun 18 -9,000 ₹212.50 ₹-1,912,500
07. Jun 18 Buy Ketankumar Zota Individual 04. Jun 18 04. Jun 18 9,000 ₹212.50 ₹1,912,500
X
Management checks
We assess Zota Health Care's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Zota Health Care has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Could The Zota Health Care Limited (NSE:ZOTA) Ownership Structure Tell Us Something Useful?

If you want to know who really controls Zota Health Care Limited (NSE:ZOTA), then you'll have to look at the makeup of its share registry. … Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. … Zota Health Care is not a large company by global standards.

Simply Wall St -

Did Zota Health Care Limited (NSE:ZOTA) Insiders Buy Up More Shares?

So before you buy or sell Zota Health Care Limited (NSE:ZOTA), you may well want to know whether insiders have been buying or selling. … But logic dictates you should pay some attention to whether insiders are buying or selling shares. … Zota Health Care Insider Transactions Over The Last Year.

Simply Wall St -

Zota Health Care Limited (NSE:ZOTA): Time For A Financial Health Check

The direct benefit for Zota Health Care Limited (NSE:ZOTA), which sports a zero-debt capital structure, to include debt in its capital structure is the reduced cost of capital. … However, the trade-off is ZOTA will have to adhere to stricter debt covenants and have less financial flexibility. … Is ZOTA growing fast enough to value financial flexibility over lower cost of capital.

Simply Wall St -

Should You Buy Zota Health Care Limited (NSE:ZOTA) For Its 1.2% Dividend?

Zota Health Care Limited (NSE:ZOTA) has started paying a dividend to shareholders. … Let's take a look at Zota Health Care in more detail. … See our latest analysis for Zota Health Care

Simply Wall St -

What Zota Health Care Limited's (NSE:ZOTA) ROE Can Tell Us

To keep the lesson grounded in practicality, we'll use ROE to better understand Zota Health Care Limited (NSE:ZOTA). … Our data shows Zota Health Care has a return on equity of 10% for the last year. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St -

Do Insiders Own Shares In Zota Health Care Limited (NSE:ZOTA)?

The big shareholder groups in Zota Health Care Limited (NSE:ZOTA) have power over the company. … Zota Health Care is not a large company by global standards. … View our latest analysis for Zota Health Care

Simply Wall St -

Don't Sell Zota Health Care Limited (NSE:ZOTA) Before You Read This

We'll look at Zota Health Care Limited's (NSE:ZOTA) P/E ratio and reflect on what it tells us about the company's share price. … Zota Health Care has a price to earnings ratio of 60.07, based on the last twelve months. … Price to Earnings Ratio = Share Price ÷ Earnings per Share (EPS)

Simply Wall St -

Why Zota Health Care Limited (NSE:ZOTA) Delivered An Inferior ROE Compared To The Industry

With an ROE of 10.42%, Zota Health Care Limited (NSE:ZOTA) returned in-line to its own industry which delivered 11.32% over the past year. … But what is more interesting is whether ZOTA can sustain or improve on this level of return. … Check out our latest analysis for Zota Health Care

Simply Wall St -

Should You Be Tempted To Sell Zota Health Care Limited (NSE:ZOTA) At Its Current PE Ratio?

and want to better understand how you can grow your money by investing in Zota Health Care Limited (NSE:ZOTA). … Zota Health Care Limited (NSE:ZOTA) is trading with a trailing P/E of 61.2x, which is higher than the industry average of 24.3x. … While ZOTA might seem like a stock to avoid or sell if you own it, it is important to understand the assumptions behind the P/E ratio before you make any investment decisions

Simply Wall St -

Are Zota Health Care Limited's (NSEI:ZOTA) Interest Costs Too High?

On top of this, ZOTA has generated cash from operations of ₹58.5M over the same time period, resulting in an operating cash to total debt ratio of 1.43x, signalling that ZOTA’s debt is appropriately covered by operating cash. … ZOTA’s high cash coverage and low debt levels indicate its ability to utilise its borrowings efficiently in order to generate ample cash flow. … ZOTA’s high cash coverage and low levels of debt indicate its ability to use its borrowings efficiently in order to produce a healthy cash flow.

Simply Wall St -

Company Info

Description

Zota Health Care Limited manufactures and markets pharmaceutical products in India and internationally. The company was founded in 1995 and is based in Surat, India.

Details
Name: Zota Health Care Limited
ZOTA
Exchange: NSEI
Founded: 1995
₹4,562,148,687
17,543,352
Website: http://www.zotahealthcare.com
Address: Zota Health Care Limited
Zota House,
2/896, Hira Modi Street,
Surat,
Gujarat, 395002,
India
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NSEI ZOTA Equity Shares National Stock Exchange of India IN INR 11. Oct 2017
Number of employees
Current staff
Staff numbers
223
Zota Health Care employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/03/23 12:54
End of day share price update: 2019/03/22 00:00
Last earnings filing: 2018/08/16
Last earnings reported: 2018/03/31
Last annual earnings reported: 2018/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.